Dubna, Russia
The Russian Corporation of Nanotechnologies is planning to construct the R1.6 billion Russia Preclinical Nanotoxicology Research Center in Dubna. Offering GLP (Good Laboratory Practice) pharmaceutical testing services, the 10,000-sm facility will support collaborative research with Moscow State University and The Lovelace Respiratory Research Institute (LRRI) of New Mexico. The project architect is HDR.
